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Background and results
Herpesviruses establish life-long persistent infections
that result in clinical manifestations ranging from mild
cold sores, to pneumonitis and cancers. Immunosup-
pressed populations, including AIDS patients, are at risk
for more serious disease outcomes. Although the a-, b-,
and g-herpesviruses infect different tissues and cause
distinct diseases, they confront many of the same chal-
lenges in producing new virions and spreading infection.
The herpesvirus families each encode a conserved ser-
ine/threonine kinase that plays an important role in
virus replication and spread. Despite the potential of
these kinases as pharmacological targets, the extent of
substrate conservation and the key common cell signal-
ling pathways targeted by these enzymes are unknown.
We applied a human protein microarray, high-through-
put approach to identifying shared substrates of the con-
served kinases from herpes simplex virus, human
cytomegalovirus, Epstein-Barr virus (EBV) and Kaposi’s
sarcoma associated herpesvirus. We identified 110
shared host substrates targeted by at least three con-
served viral kinases. Bioinformatics analyses revealed
that proteins involved in the DNA damage response
(DDR) were statistically enriched and further orthogonal
analysis led to an in-depth characterization of a histone
acetyltransferase, TIP60, as a master regulator that is
exploited by these viruses. In EBV replication, TIP60
acts both by triggering the EBV-induced DDR and by
regulating expression of viral lytic genes (Figure 1).
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1. The conserved herpesvirus kinases target the DNA
damage response (DDR) pathway.
2. The EBV kinase BGLF4 induces the DDR and regu-
lates key lytic viral genes through TIP60.
3. TIP60 knockdown impairs and g herpesvirus
replication.
4. Identification of key cellular targets of the con-
served herpesvirus kinases will facilitate the develop-
ment of broadly effective anti-viral strategies.
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